옛 화면은 좌우로 밀어 볼 수 있습니다.


  • Program
    ▶ DOWNLOAD program afile
    Program at a Glance
    09:00-10:00 Registration
    10:00-10:15 Welcome & Opening Remarks
    10:15-12:00 Session 1: Genetics vs Non-genetics Sources of Variability
    12:00-13:00 Luncheon
    13:00-14:45 Session 2: The Role of Modeling & Decision Support Tools
    14:45-15:00 Coffee/Tea Break
    15:00-16:20 Session 3: Facilitators & Barriers to Implementation
    16:20-16:45 Panel Discussion
    16:45-17:00 Closing Remarks
    Program Details
    09:00~10:00
    Registration

    10:00~10:15
    Welcome & Opening Remarks
    Jae-Gook Shin, Inje University, Korea
    Amin Rostami, University of Manchester & Certara, UK


    10:15 ~ 12:00
    Session 1: Genetics vs Non-Genetics Sources of Variability
    Co-Chair : Amin Rostami, University of Manchester & Certara, UK
    Young G. Shin, Chungnam National University, Korea

    [SS1.1] Stratified vs Individualized Dosing: Past, Present and a Future
    Amin Rostami, University of Manchester & Certara, UK

    [SS1.2] Barriers and Solutions of Incorporating Genotype Information into Drug Labeling and Clinical Practice
    Jae-Gook Shin, Inje University, Korea

    [SS1.3] Developing user friendly dose individualization tools from user-hostile models.
    Dong-Seok Yim, The Catholic University of Korea, Korea

    13:00 ~ 14:45
    Session 2: The Role of Modeling & Decision Support Tools
    Co-Chair : Masoud Jamei, Certara, UK
    Kyun Seop Bae, University of Ulsan, Korea

    [SS2.1] Model Qualification and Regulatory Approval: Glass Box vs Black Box
    Masoud Jamei, Certara, UK

    [SS2.2] Development of a Korean-Specific virtual population model for physiologically-based pharmacokinetic modeling and simulation
    Howard Lee, Seoul National University, Korea

    [SS2.3] An Industrial Perspective on Model-Informed Precision Dosing: Facilitators vs Barriers
    Holly KimKo, Janssen Research & Development of Johnson & Johnson, US

    15:00 ~ 16:20
    Session 3: Facilitators & Barriers to Implementation
    Co-Chair : Tom Polasek, Flinders University, Australia
    In-Jin Jang, Seoul National University, Korea

    [SS3.1] Clinical Implementation of Individualized Antipsychotic Treatment Guided by PBPK Modeling
    Tom Polasek, Flinders University, Australia

    [SS3.2] Modeling and Validating Pharmacological Manipulation of Circadian Rhythms for Precision Medicine
    Jae Kyoung Kim, KAIST, Korea

    [SS3.3] The Model-informed Personalized Dosing of Anti-tuberculosis Drugs
    Jae-Gook Shin, Inje University College of Medicine, Korea

    [SS3.4] Learning from the Past and a Roadmap for the Future
    Amin Rostami, University of Manchester & Certara, UK


    16:20 ~ 16:45
    Panel Discussion
    Chair : Amin Rostami, University of Manchester & Certara, UK


    16:45 ~ 17:00
    Closing Remarks
    Jae-Gook Shin, Inje University, Korea
    Amin Rostami, University of Manchester & Certara, UK